Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldfarb, S.
Right arrow Articles by Golper, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldfarb, S.
Right arrow Articles by Golper, T. A.

Journal of the American Society of Nephrology, Vol 5, 228-232, Copyright © 1994 by American Society of Nephrology

REGULAR ARTICLES

Proinflammatory cytokines and hemofiltration membranes

S Goldfarb and TA Golper
Kidney Disease Program, University of Louisville, KY.

To determine whether the clinical improvement noted in some septic patients undergoing hemofiltration is in part due to the removal of proinflammatory mediators, in vitro hemofiltration of a 1% albumin solution containing recombinant human tumor necrosis factor alpha and interleukin-1 was performed through a variety of hemofilters. Observed sieving coefficients of these cytokines was much higher (up to 0.35) than expected, considering their molecular weights of 17 kd. In addition, binding of up to 32% of the total mass to selected membranes (polyamide and AN69) was noted. These data are consistent with the concept that either the convective or adsorptive removal of proinflammatory cytokines may play role in the clinical efficacy of hemofiltration in sepsis.


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
M. R. Marshall, T. Ma, D. Galler, A. P. N. Rankin, and A. B. Williams
Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 877 - 884.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Troyanov, J. Cardinal, D. Geadah, D. Parent, S. Courteau, S. Caron, and M. Leblanc
Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters
Nephrol. Dial. Transplant., May 1, 2003; 18(5): 961 - 966.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. S. DE VRIESE, F. A. COLARDYN, J. J. PHILIPPÉ, R. C. VANHOLDER, J. H. DE SUTTER, and N. H. LAMEIRE
Cytokine Removal during Continuous Hemofiltration in Septic Patients
J. Am. Soc. Nephrol., April 1, 1999; 10(4): 846 - 853.
[Abstract] [Full Text]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673